7IQ.F REVEZ CORPORATION LTD.
- Market cap
- EUR 1.32M
- P/E
- -
- P/B
- 0.32x
- ROE
- -11.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 7IQ.F undervalued?
Graham numberThe Graham number of REVEZ CORPORATION LTD. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
REVEZ CORPORATION LTD. fundamental analysis
No fundamental analysis for REVEZ CORPORATION LTD. yet.
REVEZ CORPORATION LTD. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About REVEZ CORPORATION LTD.
Assurance Healthcare Limited, an investment holding company, operates in the healthcare business in Singapore. The company develops and distributes healthcare products and services and manages healthcare solutions through retail, direct selling, network marketing, and e-commerce. It offers managed healthcare solutions to corporations through a network of medical service providers to deliver healthcare services to the employees of corporations. It also offers various services…
Full company profileREVEZ CORPORATION LTD. financial statements
REVEZ CORPORATION LTD. annual financial statements (SGD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 7.53M | 0.00 | 304K | 588K | 740K |
| Gross Profit | -30.6K | -7.38K | -96.5K | -66.6K | 71.3K |
| Operating Income | -1.51M | -635K | -1.91M | -1.32M | -780K |
| EBITDA | - | 656K | -1.41M | -1.18M | -645K |
| Net Income | -1.93M | -4.37M | -3.03M | -1.14M | -732K |
| EPS | -0.01 | -0.03 | -0.01 | 0.00 | 0.00 |
| Balance Sheet | |||||
| Total Assets | 11.5M | 6.31M | 9.59M | 7.75M | 7.25M |
| Total Liabilities | 5.46M | 5.00M | 1.29M | 794K | 1.08M |
| Shareholders' Equity | 5.69M | 1.32M | 8.15M | 7.02M | 6.28M |
| Cash & Short-term Investments | 3.32M | 1.81M | 3.81M | 2.16M | 1.24M |
| Cash Flow | |||||
| Operating Cash Flow | -460K | -656K | -1.63M | -1.06M | -539K |
| Capital Expenditure | 2.45M | 609K | 10.0K | 445K | 241K |
| Free Cash Flow | -2.91M | -1.27M | -1.64M | -1.50M | -780K |
| Ratios | |||||
| ROE | -34.0% | -332.2% | -37.2% | -16.2% | -11.6% |
| ROA | -16.8% | -69.2% | -31.6% | -14.7% | -10.1% |
| Net Profit Margin | -25.7% | - | -997.4% | -193.2% | -98.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
REVEZ CORPORATION LTD. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | SGD 33.7K | 0.00 | - |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns REVEZ CORPORATION LTD.
- Insiders 91.43%
- Institutions 0.00%
- Public & others 8.57%
- Shares outstanding 263M
- Free float 22.6M
REVEZ CORPORATION LTD. company profile
- Company name
- REVEZ CORPORATION LTD.
- Ticker
- 7IQ.F
- ISIN
- SGXE83751573
- Exchange
- Frankfurt Exchange
- Sector
- Technology
- Industry
- IT Services
- Employees
- 8
- Fiscal year end
- December
- Address
- No.11-07, Singapore, Singapore, 049319
- Phone
- 65 6291 2691
- Website
- assurance-healthcare.com
About REVEZ CORPORATION LTD.
Assurance Healthcare Limited, an investment holding company, operates in the healthcare business in Singapore. The company develops and distributes healthcare products and services and manages healthcare solutions through retail, direct selling, network marketing, and e-commerce. It offers managed healthcare solutions to corporations through a network of medical service providers to deliver healthcare services to the employees of corporations. It also offers various services, including real-time information and cost control; work injury case management; online employment medical check-up reports; and vaccination and infectious disease testing services. The company was formerly known as Revez Corporation Ltd. and changed its name to Assurance Healthcare Limited in August 2024. The company is based in Singapore.
REVEZ CORPORATION LTD. management
4- Ms. Dan ZhangExecutive Director & Group Financial Controller · born 1983
- Mr. Fook Chuan ChewGroup MD & Executive Director
- Mr. Kuan Loong LaiCompany Secretary
- Ms. Soo Fern Lee ACISCompany Secretary